ATE76408T1 - Carbapenem-antibiotika, ein verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents

Carbapenem-antibiotika, ein verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE76408T1
ATE76408T1 AT87103189T AT87103189T ATE76408T1 AT E76408 T1 ATE76408 T1 AT E76408T1 AT 87103189 T AT87103189 T AT 87103189T AT 87103189 T AT87103189 T AT 87103189T AT E76408 T1 ATE76408 T1 AT E76408T1
Authority
AT
Austria
Prior art keywords
image
aliphatic
manufacture
pharmaceutical compositions
compositions containing
Prior art date
Application number
AT87103189T
Other languages
English (en)
Inventor
Pierre Dextraze
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE76408T1 publication Critical patent/ATE76408T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT87103189T 1986-03-06 1987-03-06 Carbapenem-antibiotika, ein verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. ATE76408T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83710186A 1986-03-06 1986-03-06
EP87103189A EP0235823B1 (de) 1986-03-06 1987-03-06 Carbapenem-Antibiotika, ein Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE76408T1 true ATE76408T1 (de) 1992-06-15

Family

ID=25273518

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87103189T ATE76408T1 (de) 1986-03-06 1987-03-06 Carbapenem-antibiotika, ein verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Country Status (7)

Country Link
EP (1) EP0235823B1 (de)
JP (1) JPS62265287A (de)
AT (1) ATE76408T1 (de)
CA (1) CA1272719A (de)
DE (1) DE3779148D1 (de)
ES (1) ES2039365T3 (de)
GR (1) GR3004658T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242914A (en) * 1988-04-01 1993-09-07 Sankyo Company, Limited 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics
ES2067534T3 (es) * 1988-04-01 1995-04-01 Sankyo Co Derivados de 2-(heterocicliltio)carbapenemo, su preparacion y su aplicacion como antibioticos.
US4962101A (en) * 1989-08-21 1990-10-09 Merck & Co., Inc. 2-(Heterocyclylalkyl)phenyl carbapenem antibacterial agents
FI96311C (fi) * 1989-12-04 1996-06-10 Squibb Bristol Myers Co Menetelmä farmaseuttisesti käyttökelpoisten 6-(1-hydroksietyyli)-3-(substituoitu tio)-7-okso-1-atsabisyklo/3.2.0/hept-2-eeni-2-karboksyylihappojohdannaisten valmistamiseksi
US5672701A (en) * 1990-01-16 1997-09-30 Bristol-Myers Squibb Company 4-substituted alkyl carbapenem antibiotics
US5227376A (en) * 1990-02-14 1993-07-13 Sumitomo Pharmaceuticals Co., Ltd. β-lactam compounds and their production
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038869A1 (de) 1980-04-30 1981-11-04 Merck & Co. Inc. Verfahren zur Herstellung von 1-Carbapenemen und Zwischenprodukte für ihre Herstellung
US4350631A (en) 1980-12-18 1982-09-21 Merck & Co., Inc. 6- and 4-Substituted-1-azabicyclo[3.2.0]heptan-3,7-dione-2-carboxylates
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
JPS5910588A (ja) 1982-06-18 1984-01-20 ブリストル―マイヤーズ スクイブ カンパニー カルバペネム抗生物質
ZA841643B (en) 1983-03-08 1984-10-31 Bristol Myers Co Carbapenem process
IE851586L (en) * 1984-07-02 1986-01-02 Interchem Internat S A I methylcarbapenems having a 2-quaternary¹heteroarylalkylthio substituent

Also Published As

Publication number Publication date
JPS62265287A (ja) 1987-11-18
GR3004658T3 (de) 1993-04-28
EP0235823A2 (de) 1987-09-09
EP0235823B1 (de) 1992-05-20
EP0235823A3 (en) 1988-04-20
CA1272719A (en) 1990-08-14
DE3779148D1 (de) 1992-06-25
ES2039365T3 (es) 1993-10-01

Similar Documents

Publication Publication Date Title
ES8407489A1 (es) Un procedimiento para la preparacion de antibioticos de carbapenem.
DE69030206D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
DK0389282T3 (da) Xanthinderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
AU618877B2 (en) New 4-fluorbenzoic derivatives, processes for preparing them and pharmaceutical compositions containing them
DE3854280D1 (de) Neue cyclische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung.
AU660469B2 (en) Pharmacologically active hydrazine derivatives and processes for the preparation thereof
ATE156829T1 (de) Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
IL102093A0 (en) 1-methylcarbapenem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
ATE76408T1 (de) Carbapenem-antibiotika, ein verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3882438D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE106078T1 (de) Verfahren zur herstellung von mono-, bi- und tricyclischen aminosäuren, zwischenprodukte dieses verfahrens sowie ein verfahren zu deren herstellung.
SE8305217L (sv) Karbapenem-antibiotika
SE8301929L (sv) Nya karbapenemderivat, forfarande for framstellning derav och nya mellanprodukter for anvendning vid dessa forfaranden
ZA932359B (en) 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
MY100602A (en) Substituted spiro pyridine derivatives, pharmaceutical composition containing them and processes for the preparation of such compounds and compositions
CY2160B1 (en) Erburnane derivatives processes for their preparation and pharmaceutical compositions containing them
ES8405399A1 (es) Un procedimiento para la preparacion de nuevos derivados de carbapenem.
ATE86993T1 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
SE8504538L (sv) Karbapenem-antibiotika
DE3851133D1 (de) Substituierte Thienoimidazol-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Magensäuresekretionshemmer.
ATE28457T1 (de) (5-(2-aminomethyl-imidazol-1-yl)-1,3-dialkyl-1h pyrazol-4-yl)(aryl)methanone und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee